Evaluate GI tolerance & acceptability of an oral nutrition supplement

• Research type

  Research Study

• Full title

  A study to evaluate the gastrointestinal tolerance and acceptability of a high energy, high protein low volume oral nutritional supplement containing calcium β-hydroxy-β-methylbutyrate (CaHMB) in adult patients with or at risk of malnutrition.

• IRAS ID

  266174

• Contact name

  Rebecca Stevenson

• Contact email

  rebecca.stevenson@abbott.com

• Sponsor organisation

  Abbott Nutrition, Abbott Laboratories

• Duration of Study in the UK

  0 years, 6 months, 0 days

• Research summary

  The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a high protein energy-dense oral nutritional supplement containing CaHMB in adult patients with or at risk of malnutrition. These data are required to support a submissions in the UK to allow for prescription in the community at NHS expense.

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  19/SC/0466

• Date of REC Opinion

  5 Nov 2019

• REC opinion

  Further Information Favourable Opinion